{
  "symbol": "GDTC",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": [
      "Biotechnology industry is prone to speculation",
      "Small market capitalization",
      "Pre-clinical stage with novel therapies"
    ],
    "riskScore": 8,
    "reason": "CytoMed Therapeutics operates in the speculative biotech sector with a small market cap and pre-clinical novel therapies, making it susceptible to retail-driven volatility."
  }
}